Join

Store

Chapters

APIC Action Center

Our Action Center makes it easy to action send a relevant letter to your legislators in seconds.

Take Action Now
Menu
Back to Policy Updates

FDA/FTC Issue Warning for Unapproved COVID Product

FDA/FTC Issue Warning for Unapproved COVID Product

9/28/22 — The FDA issued a warning letter jointly with the Federal Trade Commission to Bespoke Apothecary LLC for selling unapproved and misbranded COVID kit and Post Virus Recovery Herbal Tea products as drugs for use in treating or preventing COVID-19.